• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘磷脂合酶2的敲低通过降低小鼠原代成骨细胞中RANKL的表达来抑制破骨细胞生成。

Knockdown of sphingomyelin synthase 2 inhibits osteoclastogenesis by decreasing RANKL expression in mouse primary osteoblasts.

作者信息

Yoshikawa Yoshihiro, Yoshizawa Tatsuya, Domae Eisuke, Hirai Yuya, Kamada Aiko, Okazaki Toshiro, Ikeo Takashi

机构信息

Department of Biochemistry, Osaka Dental University.

Department of Medical Biochemistry, Faculty of Life Sciences, Kumamoto University.

出版信息

Biomed Res. 2019;40(5):189-196. doi: 10.2220/biomedres.40.189.

DOI:10.2220/biomedres.40.189
PMID:31597904
Abstract

Sphingomyelin is a major lipid of the plasma membrane and is enriched in microdomains of the plasma membrane that are critical for signal transduction. However, the function of sphingomyelin in the cell membrane of osteoblasts has not been clarified. Therefore, we examined how sphingomyelin synthase 2 (SMS2) affects osteoclast differentiation by osteoblasts. We knocked down the expression of SMS2 with siRNA targeting the Sgms2 gene in mouse primary osteoblasts. The effects of SMS2 knockdown in osteoblasts were examined using polymerase chain reaction and western blotting. The knockdown of SMS2 suppressed the formation of TRAP-positive multinucleated cells by co-culture of osteoblasts and bone marrow cells compared to the control. We found that receptor activator of nuclear factor κB ligand (RANKL) mRNA expression was significantly reduced by 1,25(OH)D stimulation in SMS2 siRNA osteoblasts. The knockdown of SMS2 repressed the expression of retinoid-X-receptor-α (RXRα) regardless of 1,25(OH)D stimulation. TRAP-positive multinucleated cell formation was significantly reduced by RXRα siRNA in osteoblasts in a co-culture system. These results suggest that SMS2 regulates osteoclast differentiation by inducing RANKL expression via RXRα.

摘要

鞘磷脂是质膜的主要脂质,在质膜的微结构域中含量丰富,这些微结构域对信号转导至关重要。然而,鞘磷脂在成骨细胞膜中的功能尚未阐明。因此,我们研究了鞘磷脂合成酶2(SMS2)如何影响成骨细胞介导的破骨细胞分化。我们用靶向Sgms2基因的siRNA敲低了小鼠原代成骨细胞中SMS2的表达。使用聚合酶链反应和蛋白质印迹法检测了SMS2敲低对成骨细胞的影响。与对照组相比,SMS2的敲低抑制了成骨细胞与骨髓细胞共培养时TRAP阳性多核细胞的形成。我们发现,在SMS2 siRNA转染的成骨细胞中,1,25(OH)D刺激显著降低了核因子κB受体激活剂配体(RANKL)mRNA的表达。无论是否有1,25(OH)D刺激,SMS2的敲低均抑制了视黄酸X受体α(RXRα)的表达。在共培养系统中,RXRα siRNA显著减少了成骨细胞中TRAP阳性多核细胞的形成。这些结果表明,SMS2通过RXRα诱导RANKL表达来调节破骨细胞分化。

相似文献

1
Knockdown of sphingomyelin synthase 2 inhibits osteoclastogenesis by decreasing RANKL expression in mouse primary osteoblasts.鞘磷脂合酶2的敲低通过降低小鼠原代成骨细胞中RANKL的表达来抑制破骨细胞生成。
Biomed Res. 2019;40(5):189-196. doi: 10.2220/biomedres.40.189.
2
Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.鞘磷脂合酶 1 缺乏而非鞘磷脂合酶 2 缺乏导致成骨细胞分化受损,从而减少骨形成。
Mol Med. 2019 Dec 17;25(1):56. doi: 10.1186/s10020-019-0123-0.
3
Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.成骨细胞的核因子κB信号通路参与1α, 25(OH)2D3体外诱导破骨样细胞的形成。
Int J Clin Exp Pathol. 2015 May 1;8(5):5988-96. eCollection 2015.
4
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
5
RNA interference-mediated knockdown of Smad1 inhibits receptor activator of nuclear factor κB ligand expression induced by BMP-2 in primary osteoblasts.RNA干扰介导的Smad1基因敲低抑制了原代成骨细胞中由骨形态发生蛋白-2诱导的核因子κB受体激活剂配体的表达。
Arch Oral Biol. 2015 Sep;60(9):1319-26. doi: 10.1016/j.archoralbio.2015.06.001. Epub 2015 Jun 10.
6
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.分泌型卷曲相关蛋白-1抑制RANKL依赖性破骨细胞形成。
J Bone Miner Res. 2004 Nov;19(11):1873-81. doi: 10.1359/JBMR.040807. Epub 2004 Aug 16.
7
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts.AMP 激酶在破骨细胞分化中作为 RANKL 的负调节剂。
Bone. 2010 Nov;47(5):926-37. doi: 10.1016/j.bone.2010.08.001. Epub 2010 Aug 7.
8
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.胞壁酰二肽通过成骨细胞中核苷酸结合寡聚化结构域2介导的信号传导增强脂多糖、白细胞介素-1α和肿瘤坏死因子-α诱导的破骨细胞形成。
J Immunol. 2005 Aug 1;175(3):1956-64. doi: 10.4049/jimmunol.175.3.1956.
9
Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.抑制鞘磷脂合酶(SMS)会影响细胞内鞘磷脂的积累以及质膜脂质组织。
Biochim Biophys Acta. 2007 Sep;1771(9):1186-94. doi: 10.1016/j.bbalip.2007.05.007. Epub 2007 Jun 6.
10
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.一种Jak1/2抑制剂,巴瑞替尼,在体外通过抑制成骨细胞中RANKL的表达来抑制破骨细胞生成。
PLoS One. 2017 Jul 14;12(7):e0181126. doi: 10.1371/journal.pone.0181126. eCollection 2017.

引用本文的文献

1
A novel SGMS2 mutation associated with high bone mass; description of an affected family with recurrent fragility fractures.一种与高骨量相关的新型SGMS2突变;一个患有复发性脆性骨折的患病家族的描述。
Bone Rep. 2025 Mar 5;24:101833. doi: 10.1016/j.bonr.2025.101833. eCollection 2025 Mar.
2
SGMS1 facilitates osteogenic differentiation of MSCs and strengthens osteogenesis-angiogenesis coupling by modulating Cer/PP2A/Akt pathway.SGMS1通过调节神经酰胺/蛋白磷酸酶2A/蛋白激酶B途径促进间充质干细胞的成骨分化并加强成骨-血管生成耦合。
iScience. 2024 Mar 5;27(4):109358. doi: 10.1016/j.isci.2024.109358. eCollection 2024 Apr 19.
3
Sphingolipid-Induced Bone Regulation and Its Emerging Role in Dysfunction Due to Disease and Infection.
鞘脂诱导的骨调节及其在疾病和感染所致功能障碍中的新作用。
Int J Mol Sci. 2024 Mar 5;25(5):3024. doi: 10.3390/ijms25053024.
4
in primary osteoporosis with facial nerve palsy.在原发性骨质疏松合并面神经麻痹时。
Front Endocrinol (Lausanne). 2023 Oct 11;14:1224318. doi: 10.3389/fendo.2023.1224318. eCollection 2023.
5
Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent Gene Variant.临床和遗传特征的颅 doughnut 病变与骨脆性在三个家庭的复发基因变异。
Int J Mol Sci. 2023 Apr 28;24(9):8021. doi: 10.3390/ijms24098021.
6
Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.早发性骨质疏松症:罕见的单基因形式阐明了 I 型胶原以外的疾病发病机制的复杂性。
J Bone Miner Res. 2022 Sep;37(9):1623-1641. doi: 10.1002/jbmr.4668. Epub 2022 Sep 11.
7
Sphingomyelin Synthase Family and Phospholipase Cs.鞘磷脂合成酶家族和磷脂酶 C。
Adv Exp Med Biol. 2022;1372:77-86. doi: 10.1007/978-981-19-0394-6_7.
8
The Role of Sphingolipid Metabolism in Bone Remodeling.鞘脂代谢在骨重塑中的作用。
Front Cell Dev Biol. 2021 Nov 29;9:752540. doi: 10.3389/fcell.2021.752540. eCollection 2021.
9
Calvarial doughnut lesions with bone fragility in a French-Canadian family; case report and review of the literature.法裔加拿大家庭中伴有骨脆性的颅骨环形病变;病例报告及文献综述
Bone Rep. 2021 Aug 25;15:101121. doi: 10.1016/j.bonr.2021.101121. eCollection 2021 Dec.
10
Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models.鞘磷脂合酶调控的神经酰胺/鞘磷脂变阻器与小鼠模型中的慢性疾病
J Lipid Atheroscler. 2020 Sep;9(3):380-405. doi: 10.12997/jla.2020.9.3.380. Epub 2020 Jul 29.